Publication | Closed Access

Microbiological rationale for the utilisation of prulifloxacin, a new fluoroquinolone, in the eradication of serious infections caused by Pseudomonas aeruginosa

Microbiological RationaleAntimicrobial SusceptibilityAntibioticsPseudomonas AeruginosaAntimicrobial ChemotherapyMicrobiologyInfection ControlAntimicrobial CompoundNew FluoroquinoloneMedicineClinical MicrobiologyAntimicrobial Resistance